Hi, what are you looking for?
– The Wall Street offering of road accident avoidance technology developer Mobileye(NYSE: MBLY), which raised $1.023 billion a record IPO for an Israeli...
– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. – The shares of three Israeli biomedical companies that...
– READ MORE: MobilEye Hopes To Be Worth More Than $2.7 Billion After Its IPO Mobileye Files To Raise $100 Million In NYSE IPO Israel’s MobilEye...
– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the...
– The clinical stage biotech company is selling 5.4 million ordinary shares at $12 each. Clinical-stage biotech company VBL Therapeutics has announced the pricing...
– – Collision avoidance solutions developer Mobileye has increased the amount of money it plans raising in its NYSE IPO later this week. The...
– Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified. – Six Israeli...
– The collision avoidance solutions company also published the names of its shareholders. – Collision avoidance solutions developer Mobileye has updated the filing...
– Marc Jacobs International has appointed Sebastian Suhl its new CEO – High fashion firm Marc Jacobs International has appointed Sebastian Suhl its new...
The Israeli company will raise $75 million, down from the $100 million it attempted to raise in March. The IPO of digital ad...